{"entity":{"type":"insider","cik":"0001532218","url":"/insider/0001532218","json_url":"/insider/0001532218.json","name":"Patel Sanj K","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":87,"n_filings":28,"first":"2012-03-27","last":"2026-05-01","span_basis":"filed_date"},"name_variants":[{"name":"Patel Sanj K","source":"filing","n_filings":28,"first_seen":"2012-03-27","last_seen":"2026-05-01"}],"transactions":[{"id":5834604,"accession":"0001532218-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001532218-26-000008","line_url":"/filing/0001532218-26-000008#line-2","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48565.0,"shares_display":"48,565","price_per_share":54.02,"price_display":"54.02","price_state":"stated","total_value":2623481.3,"total_display":"2,623,481.30","total_whole":"2,623,481","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-01","scope":"insider"},{"id":6039118,"accession":"0001532218-26-000006","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001532218-26-000006","line_url":"/filing/0001532218-26-000006#line-10","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2141.0,"shares_display":"2,141","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":115635.41,"total_display":"115,635.41","total_whole":"115,635","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-30","filed_date":"2026-04-30","scope":"insider"},{"id":6039112,"accession":"0001532218-26-000006","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001532218-26-000006","line_url":"/filing/0001532218-26-000006#line-8","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22544.0,"shares_display":"22,544","price_per_share":54.01,"price_display":"54.01","price_state":"stated","total_value":1217601.44,"total_display":"1,217,601.44","total_whole":"1,217,601","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-29","filed_date":"2026-04-30","scope":"insider"},{"id":6039106,"accession":"0001532218-26-000006","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001532218-26-000006","line_url":"/filing/0001532218-26-000006","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":483654.0,"shares_display":"483,654","price_per_share":51.859369053083405,"price_display":"51.86","price_state":"stated","total_value":25081991.28,"total_display":"25,081,991.28","total_whole":"25,081,991","shares_owned_after":51750.0,"shares_owned_after_display":"51,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-28","filed_date":"2026-04-30","scope":"insider","n_lines":4},{"id":5756431,"accession":"0001532218-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001532218-26-000004","line_url":"/filing/0001532218-26-000004#line-2","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7278.0,"shares_display":"7,278","price_per_share":50.01,"price_display":"50.01","price_state":"stated","total_value":363972.78,"total_display":"363,972.78","total_whole":"363,973","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-06","filed_date":"2026-04-08","scope":"insider"},{"id":5013670,"accession":"0001532218-25-000005","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001532218-25-000005","line_url":"/filing/0001532218-25-000005#line-7","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97390.0,"shares_display":"97,390","price_per_share":38.83,"price_display":"38.83","price_state":"stated","total_value":3781653.7,"total_display":"3,781,653.70","total_whole":"3,781,654","shares_owned_after":111794.0,"shares_owned_after_display":"111,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-22","filed_date":"2025-10-22","scope":"insider"},{"id":5013659,"accession":"0001532218-25-000005","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001532218-25-000005","line_url":"/filing/0001532218-25-000005#line-5","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39331.0,"shares_display":"39,331","price_per_share":38.77,"price_display":"38.77","price_state":"stated","total_value":1524862.87,"total_display":"1,524,862.87","total_whole":"1,524,863","shares_owned_after":111794.0,"shares_owned_after_display":"111,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-21","filed_date":"2025-10-22","scope":"insider"},{"id":5013653,"accession":"0001532218-25-000005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001532218-25-000005","line_url":"/filing/0001532218-25-000005","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":121248.0,"shares_display":"121,248","price_per_share":38.90385837292162,"price_display":"38.90","price_state":"stated","total_value":4717015.02,"total_display":"4,717,015.02","total_whole":"4,717,015","shares_owned_after":134108.0,"shares_owned_after_display":"134,108","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-20","filed_date":"2025-10-22","scope":"insider","n_lines":2},{"id":4281318,"accession":"0001415889-25-014744","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-25-014744","line_url":"/filing/0001415889-25-014744#line-6","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62116.0,"shares_display":"62,116","price_per_share":27.33,"price_display":"27.33","price_state":"stated","total_value":1697630.28,"total_display":"1,697,630.28","total_whole":"1,697,630","shares_owned_after":96674.0,"shares_owned_after_display":"96,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-28","filed_date":"2025-05-28","scope":"insider"},{"id":4281312,"accession":"0001415889-25-014744","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-25-014744","line_url":"/filing/0001415889-25-014744#line-4","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19317.0,"shares_display":"19,317","price_per_share":27.01,"price_display":"27.01","price_state":"stated","total_value":521752.17,"total_display":"521,752.17","total_whole":"521,752","shares_owned_after":96674.0,"shares_owned_after_display":"96,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-27","filed_date":"2025-05-28","scope":"insider"},{"id":4281305,"accession":"0001415889-25-014744","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-014744","line_url":"/filing/0001415889-25-014744#line-2","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4837.0,"shares_display":"4,837","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":130599.0,"total_display":"130,599.00","total_whole":"130,599","shares_owned_after":96674.0,"shares_owned_after_display":"96,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-23","filed_date":"2025-05-28","scope":"insider"},{"id":4501040,"accession":"0001415889-25-014167","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-014167","line_url":"/filing/0001415889-25-014167#line-2","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2349.0,"shares_display":"2,349","price_per_share":27.02,"price_display":"27.02","price_state":"stated","total_value":63469.98,"total_display":"63,469.98","total_whole":"63,470","shares_owned_after":96674.0,"shares_owned_after_display":"96,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-22","scope":"insider"},{"id":4500997,"accession":"0001415889-25-013170","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-013170","line_url":"/filing/0001415889-25-013170#line-2","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2872.0,"shares_display":"2,872","price_per_share":27.03,"price_display":"27.03","price_state":"stated","total_value":77630.16,"total_display":"77,630.16","total_whole":"77,630","shares_owned_after":96674.0,"shares_owned_after_display":"96,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-13","filed_date":"2025-05-15","scope":"insider"},{"id":4146452,"accession":"0001415889-25-012571","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-25-012571","line_url":"/filing/0001415889-25-012571#line-6","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6029.0,"shares_display":"6,029","price_per_share":27.05,"price_display":"27.05","price_state":"stated","total_value":163084.45,"total_display":"163,084.45","total_whole":"163,084","shares_owned_after":96674.0,"shares_owned_after_display":"96,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-09","filed_date":"2025-05-09","scope":"insider"},{"id":4146447,"accession":"0001415889-25-012571","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-25-012571","line_url":"/filing/0001415889-25-012571#line-4","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101.0,"shares_display":"101","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":2727.0,"total_display":"2,727.00","total_whole":"2,727","shares_owned_after":96674.0,"shares_owned_after_display":"96,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-08","filed_date":"2025-05-09","scope":"insider"},{"id":4146442,"accession":"0001415889-25-012571","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-012571","line_url":"/filing/0001415889-25-012571#line-2","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1965.0,"shares_display":"1,965","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":53055.0,"total_display":"53,055.00","total_whole":"53,055","shares_owned_after":96674.0,"shares_owned_after_display":"96,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-07","filed_date":"2025-05-09","scope":"insider"},{"id":2662634,"accession":"0001415889-24-026451","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-026451","line_url":"/filing/0001415889-24-026451#line-2","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89561.0,"shares_display":"89,561","price_per_share":23.0,"price_display":"23.00","price_state":"stated","total_value":2059903.0,"total_display":"2,059,903.00","total_whole":"2,059,903","shares_owned_after":79551.0,"shares_owned_after_display":"79,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-06","filed_date":"2024-11-08","scope":"insider"},{"id":3237000,"accession":"0001415889-24-020108","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-020108","line_url":"/filing/0001415889-24-020108","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136124.0,"shares_display":"136,124","price_per_share":25.652693426581646,"price_display":"25.65","price_state":"stated","total_value":3491947.24,"total_display":"3,491,947.24","total_whole":"3,491,947","shares_owned_after":63012.0,"shares_owned_after_display":"63,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-23","filed_date":"2024-07-25","scope":"insider","n_lines":3},{"id":2329195,"accession":"0001415889-24-007569","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-007569","line_url":"/filing/0001415889-24-007569#line-1","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Common Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65012.0,"shares_display":"65,012","price_per_share":21.02,"price_display":"21.02","price_state":"stated","total_value":1366552.24,"total_display":"1,366,552.24","total_whole":"1,366,552","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider"},{"id":2743761,"accession":"0001415889-24-007083","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-007083","line_url":"/filing/0001415889-24-007083#line-3","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Common Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5582.0,"shares_display":"5,582","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":117222.0,"total_display":"117,222.00","total_whole":"117,222","shares_owned_after":65012.0,"shares_owned_after_display":"65,012","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-06","filed_date":"2024-03-06","scope":"insider"},{"id":2743756,"accession":"0001415889-24-007083","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-007083","line_url":"/filing/0001415889-24-007083","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (CHAIRMAN & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN & CEO","security_title":"Class A Common Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12742.0,"shares_display":"12,742","price_per_share":21.490649819494585,"price_display":"21.49","price_state":"stated","total_value":273833.86,"total_display":"273,833.86","total_whole":"273,834","shares_owned_after":73930.0,"shares_owned_after_display":"73,930","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider","n_lines":2},{"id":5355902,"accession":"0001179110-21-001553","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001179110-21-001553","line_url":"/filing/0001179110-21-001553","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2737.0,"shares_display":"2,737","price_per_share":23.064154183412494,"price_display":"23.06","price_state":"stated","total_value":63126.59,"total_display":"63,126.59","total_whole":"63,127","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-10","scope":"insider","n_lines":2},{"id":5355887,"accession":"0001179110-21-001553","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-21-001553","line_url":"/filing/0001179110-21-001553","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43970.0,"shares_display":"43,970","price_per_share":23.06144098248806,"price_display":"23.06","price_state":"stated","total_value":1014011.56,"total_display":"1,014,011.56","total_whole":"1,014,012","shares_owned_after":84473.0,"shares_owned_after_display":"84,473","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-10","scope":"insider","n_lines":2},{"id":5355872,"accession":"0001179110-21-001553","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-21-001553","line_url":"/filing/0001179110-21-001553","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9452.0,"shares_display":"9,452","price_per_share":23.0,"price_display":"23.00","price_state":"stated","total_value":217396.0,"total_display":"217,396.00","total_whole":"217,396","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider","n_lines":2},{"id":2623663,"accession":"0001179110-20-010450","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-20-010450","line_url":"/filing/0001179110-20-010450","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250030.0,"shares_display":"250,030","price_per_share":21.02,"price_display":"21.02","price_state":"stated","total_value":5255630.6,"total_display":"5,255,630.60","total_whole":"5,255,631","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-12","filed_date":"2020-10-14","scope":"insider","n_lines":2},{"id":2623655,"accession":"0001179110-20-010450","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-010450","line_url":"/filing/0001179110-20-010450","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1542.0,"shares_display":"1,542","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":32382.0,"total_display":"32,382.00","total_whole":"32,382","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-09","filed_date":"2020-10-14","scope":"insider","n_lines":2},{"id":2064285,"accession":"0001179110-20-003417","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-003417","line_url":"/filing/0001179110-20-003417#line-1","is_derivative":false,"issuer_cik":"0001532218","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001532218","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (Chairman & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33115.0,"shares_display":"33,115","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":662300.0,"total_display":"662,300.00","total_whole":"662,300","shares_owned_after":212570.0,"shares_owned_after_display":"212,570","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-06","filed_date":"2020-03-10","scope":"insider"},{"id":6341958,"accession":"0001246360-14-004749","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001246360-14-004749","line_url":"/filing/0001246360-14-004749","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":88.8472656,"price_display":"88.85","price_state":"stated","total_value":4442363.28,"total_display":"4,442,363.28","total_whole":"4,442,363","shares_owned_after":1031.0,"shares_owned_after_display":"1,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-17","filed_date":"2014-12-19","scope":"insider","n_lines":4},{"id":7037972,"accession":"0001246360-14-000472","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001246360-14-000472","line_url":"/filing/0001246360-14-000472","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50971.0,"shares_display":"50,971","price_per_share":87.97067057738714,"price_display":"87.97","price_state":"stated","total_value":4483953.05,"total_display":"4,483,953.05","total_whole":"4,483,953","shares_owned_after":27185.0,"shares_owned_after_display":"27,185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-29","filed_date":"2014-01-30","scope":"insider","n_lines":5},{"id":7037962,"accession":"0001246360-14-000472","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001246360-14-000472","line_url":"/filing/0001246360-14-000472#line-7","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32609.0,"shares_display":"32,609","price_per_share":88.38,"price_display":"88.38","price_state":"stated","total_value":2881983.42,"total_display":"2,881,983.42","total_whole":"2,881,983","shares_owned_after":10245.0,"shares_owned_after_display":"10,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-28","filed_date":"2014-01-30","scope":"insider"},{"id":7037960,"accession":"0001246360-14-000472","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001246360-14-000472","line_url":"/filing/0001246360-14-000472#line-6","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001532218","owner_name":"Patel Sanj K","owner_display_name":"Patel Sanj K","owner_url":"/insider/0001532218","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9506.0,"shares_display":"9,506","price_per_share":87.16,"price_display":"87.16","price_state":"stated","total_value":828542.96,"total_display":"828,542.96","total_whole":"828,543","shares_owned_after":42854.0,"shares_owned_after_display":"42,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-28","filed_date":"2014-01-30","scope":"insider"}],"collapsed":true,"next_cursor":"2014-01-28|7037960","ledger_fault":false,"count":{"value":87,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":87,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":87},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001730430","name":"Kiniksa Pharmaceuticals International, plc","url":"/issuer/0001730430","role":"Director, Officer (CHAIRMAN & CEO)","n_filings":15,"first_seen":"2020-03-10","last_seen":"2026-05-01"},{"type":"issuer","type_label":"ISSUER","cik":"0000911326","name":"SYNAGEVA BIOPHARMA CORP","url":"/issuer/0000911326","role":"Director, Officer (President & CEO)","n_filings":13,"first_seen":"2012-03-27","last_seen":"2014-12-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001532218","retrieved_at":"2026-08-23T17:55:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}